Table 2.
Effect of repeated oral administration of ammonium molybdate along with copper sulfate (II) pentahydrate in group 2 goats for 30 consecutive days on hematological parameters (mean ± SE) (n = 4)
| Parameter | Days |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Treatment days |
Post-treatment days |
|||||||||
| 0 | 1 | 3 | 7 | 14 | 21 | 28 | 30 | 7 | 14 | |
| Hb (gm/dl) | 10.65 ± 0.33 | 10.78 ± 0.12 | 10.85 ± 0.17 | 10.73 ± 0.70 | 10.68 ± 0.31 | 10.45 ± 0.37 | 10.30 ± 0.45 | 10.35 ± 0.54 | 10.10 ± 0.52 | 10.63 ± 0.44 |
| PCV (%) | 28.75 ± 1.49 | 29.75 ± 1.11 | 29.50 ± 0.65 | 29.00 ± 1.58 | 30.75 ± 1.11 | 29.50 ± 0.65 | 28.00 ± 1.41 | 28.50 ± 1.56 | 29.00 ± 2.97 | 29.75 ± 2.10 |
| TLC (× 103/mm3) | 9.51 ± 0.35 | 8.54 ± 0.21 | 9.65 ± 0.39 | 9.73 ± 0.54 | 9.82 ± 0.60 | 9.80 ± 0.47 | 9.50 ± 0.58 | 8.51 ± 0.43 | 9.69 ± 0.48 | 9.77 ± 0.37 |
| TEC (× 106/mm3) | 11.02 ± 0.52 | 10.84 ± 0.62 | 10.91 ± 0.63 | 10.82 ± 0.52 | 11.06 ± 0.53 | 10.74 ± 0.67 | 10.52 ± 0.48 | 10.23 ± 0.56 | 10.30 ± 0.40 | 10.61 ± 0.25 |
| Lymphocytes | 57.50 ± 3.80 | 56.50 ± 1.19 | 60.75 ± 0.85 | 58.75 ± 1.89 | 57.75 ± 2.02 | 55.25 ± 1.11 | 49.75 ± 0.85 | 48.75 ± 1.38 | 55.00 ± 1.78 | 54.25 ± 2.06 |
| Neutrophils | 32.00 ± 1.29 | 35.00 ± 2.65 | 31.25 ± 1.70 | 32.75 ± 2.25 | 29.50 ± 2.02 | 28.75 ± 0.95 | 34.00 ± 3.34 | 35.50 ± 2.84 | 35.00 ± 1.96 | 33.50 ± 2.60 |
| Monocytes | 4.50 ± 0.65 | 4.75 ± 0.48 | 5.00 ± 0.71 | 4.75 ± 0.48 | 4.25 ± 0.48 | 4.25 ± 1.11 | 3.25 ± 0.48 | 3.00 ± 0.41 | 2.75 ± 0.75 | 4.50 ± 0.65 |
| Eosinophils | 2.25 ± 0.63 | 1.50 ± 0.29 | 1.75 ± 0.25 | 1.75 ± 0.48 | 1.75 ± 0.25 | 2.00 ± 0.91 | 2.75 ± 0.85 | 2.75 ± 0.48 | 2.50 ± 0.87 | 2.50 ± 0.65 |
| Basophils | 1.50 ± 0.29 | 1.25 ± 0.48 | 1.75 ± 0.25 | 1.75 ± 0.48 | 2.25 ± 0.25 | 2.00 ± 0.91 | 2.00 ± 0.41 | 1.75 ± 0.48 | 1.50 ± 0.29 | 1.25 ± 0.48 |
| MCV (fl) | 26.32 ± 2.13 | 27.69 ± 1.84 | 27.25 ± 1.34 | 27.15 ± 2.59 | 27.89 ± 0.88 | 27.78 ± 1.83 | 26.92 ± 2.37 | 27.93 ± 1.04 | 28.42 ± 3.39 | 28.07 ± 1.99 |
| MCH (pg) | 9.75 ± 0.63 | 10.02 ± 0.50 | 10.04 ± 0.60 | 9.91 ± 0.46 | 9.72 ± 0.53 | 9.89 ± 0.92 | 9.87 ± 0.68 | 10.25 ± 0.94 | 9.82 ± 0.42 | 10.05 ± 0.58 |
| MCHC (%) | 37.47 ± 2.93 | 36.36 ± 1.32 | 36.85 ± 1.15 | 37.54 ± 3.87 | 34.91 ± 2.00 | 35.43 ± 1.07 | 36.93 ± 1.54 | 36.67 ± 2.85 | 36.13 ± 4.65 | 36.41 ± 3.46 |
| ESR (mm/24 hours) | 8.50 ± 0.65 | 7.75 ± 0.63 | 7.75 ± 0.63 | 7.00 ± 0.71 | 8.00 ± 0.41 | 7.75 ± 0.85 | 7.50 ± 0.96 | 8.25 ± 0.63 | 8.25 ± 1.49 | 8.75 ± 0.95 |
a,b
Significantly different as compared with pre-exposure (0 day) value of the same group at 5% (P<0.05) and 1% (P<0.01), respectively; Hb - hemoglobin; PCV - packed cell volume; TLC - total leukocyte count; TEC - total erythrocyte count; MCV - mean corpuscular volume; MCH - mean corpuscular hemoglobin; MCHC - mean corpuscular hemoglobin concentration; ESR - erythrocyte